Stephen Hill - Histogen VP Controller
| HSTODelisted Stock | USD 0.03 0.00 0.00% |
Insider
Stephen Hill is VP Controller of Histogen
| Phone | 858 526 3100 |
| Web | https://www.histogen.com |
Stephen Hill Latest Insider Activity
Tracking and analyzing the buying and selling activities of Stephen Hill against Histogen stock is an integral part of due diligence when investing in Histogen. Stephen Hill insider activity provides valuable insight into whether Histogen is net buyers or sellers over its current business cycle. Note, Histogen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Histogen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Stephen Hill over two months ago Disposition of 700000 shares by Stephen Hill of Lyell Immunopharma at 5.98 subject to Rule 16b-3 | ||
Stephen Hill over six months ago Acquisition by Stephen Hill of 85000 shares of Lyell Immunopharma at 1.87 subject to Rule 16b-3 | ||
Stephen Hill over six months ago Acquisition by Stephen Hill of 700000 shares of Lyell Immunopharma at 1.87 subject to Rule 16b-3 | ||
Stephen Hill over a year ago Acquisition by Stephen Hill of 40000 shares of Lyell Immunopharma subject to Rule 16b-3 |
Histogen Management Efficiency
The company has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities.Histogen currently holds 4.63 M in liabilities with Debt to Equity (D/E) ratio of 0.31, which is about average as compared to similar companies. Histogen has a current ratio of 12.96, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Histogen's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Justin Trojanowski | Tempest Therapeutics | 36 | |
| Gregory MBA | Artelo Biosciences | 62 | |
| Gideon Shapiro | Bright Minds Biosciences | N/A | |
| Wilson Wong | Senti Biosciences | N/A | |
| Jan MSc | Bright Minds Biosciences | 60 | |
| Miranda MBA | Entera Bio | 48 | |
| Hillel MBA | Entera Bio | 47 | |
| Anne Moon | Tempest Therapeutics | N/A | |
| RAC Sakai | Tempest Therapeutics | N/A | |
| Tomasz George | Virax Biolabs Group | 40 | |
| James Foster | Virax Biolabs Group | 40 | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Petpiboon Prasit | Tempest Therapeutics | N/A | |
| Craig Esq | Cingulate | 51 | |
| Robert McRae | Palisade Bio | N/A | |
| Elif McDonald | Curis Inc | N/A | |
| Susan Dexter | Sonnet Biotherapeutics Holdings | 70 | |
| Steven Reich | Artelo Biosciences | 78 | |
| Dr Dubensky | Tempest Therapeutics | 66 | |
| FCCP MD | Bright Minds Biosciences | 61 | |
| Philip Lee | Senti Biosciences | 42 | |
Management Performance
| Return On Equity | -1.2 | |||
| Return On Asset | -0.54 |
Histogen Leadership Team
Elected by the shareholders, the Histogen's board of directors comprises two types of representatives: Histogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Histogen. The board's role is to monitor Histogen's management team and ensure that shareholders' interests are well served. Histogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Histogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Hill, VP Controller | ||
| Steven Mento, Interim Chairman | ||
| Thomas Hubka, Director Sec | ||
| Gail Naughton, Founder Advisor | ||
| Susan Knudson, CEO, President |
Histogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Histogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.2 | |||
| Return On Asset | -0.54 | |||
| Operating Margin | (705.00) % | |||
| Current Valuation | (4.46 M) | |||
| Shares Outstanding | 4.27 M | |||
| Shares Owned By Insiders | 2.85 % | |||
| Number Of Shares Shorted | 67.03 K | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 4.50 X | |||
| Revenue | 19 K |
Pair Trading with Histogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Histogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will appreciate offsetting losses from the drop in the long position's value.Moving against Histogen Stock
The ability to find closely correlated positions to Histogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Histogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Histogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Histogen to buy it.
The correlation of Histogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Histogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |